Table 3

Bivariable and multivariable logistics regression analysis of variables associated with glycaemic levels of patients with T2DM

Variables
Glycaemic controlCOR (95% CI)P valueAOR (95% CI)P value
PoorGood
Residency
 Urban165720.704 (0.447 to 1.107)0.1290.934 (0.377 to 2.311)0.882
 Rural1273911
SMBG practice
 No236426.923 (4.277 to 11.208)07.572 (3.117 to 18.394)0.000*
 Yes566911
BMI (kg/m2)
 Underweight2770.321 (0.099 to 1.0403)0.0340.196 (0.024 to 1.566)0.124
 Normal152830.153 (0.064 to 0.366)00.119 (0.023 to 0.611)0.011*
 Overweight41150.228 (0.082 to 0.633)0.0050.450 (0.062 to 3.226)0.43
 Obesity72611
Smoking status
 Currently smoker42270.613 (0.350 to 1.073)0.010.315 (0.101 to 1.087)0.055
 Previously smoker80171.855 (1.023 to 3.362)0.0871.588 (0.555 to 4.530)0.047
 Nonsmoker1706710.04210.389
Physical activity
 Sedentary132490.634 (0.336 to 1.197)0.160.686 (0.219 to 2.148)0.518
 Moderate92460.471 (0.246 to 0.901)0.0230.445 (0.132 to 1.498)0.191
 Vigorous681611
Insulin type
 Premixed43470.235 (0.143 to 0.386)00.356 (0.127 to 0.959)0.040*
 NPH2496411
Amlodipine
 Yes54121.872 (0.960 to 3.651)0.0661.579 (0.430 to 5.793)0.491
 No2389911
Atenolol
 Yes1090.402 (0.159 to 1.017)0.0540.323 (0.091 to 1.148)0.081
 No28210211
Lipid lowering agent
 Atorvastatin109341.924 (0.955 to 3.873)0.0672.241 (0.889 to 5.583)0.083
 Simvastatin301811
Frequent clinical hypoglycaemia
 Yes24280.265 (0.146 to 0.483)00.779 (0.230 to 2.635)0.688
 No2688311
SBP (mm Hg)
 ≥140110291.709 (1.052 to 2.776)0.030.860 (0.356 to 2.078)0.737
 <1401828211
  • *Indicates the statistically significant at p<0.05.

  • AOR, adjusted OR; BMI, body mass index; COR, crude OR; NPH, neutral protamine hagedorn; SBP, systolic blood pressure; SMBG, self-monitoring blood glucose; T2DM, type 2 diabetes mellitus.